Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients

Author(s): Sturn Kayla M, Collin Michael

Issue: May/Jun 2016 - Volume 20, Number 3
View All Articles in Issue

Page(s): 197-201

Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients Page 1

Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients Page 2

Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients Page 3

Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients Page 4

Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients Page 5

Download in electronic PDF format for $65

Abstract: Naltrexone (an opioid antagonist) has long been used in patients overcoming alcohol and opioid dependency. However, at doses one-tenth of those commonly prescribed for the above conditions, an unexpected effect occurs that aids in alleviating pain. Although there are currently no randomized clinical trials supporting the use of low-dose naltrexone, we present a case study describing the impact of compounding low-dose naltrexone that has dramatically improved the patient’s pain symptoms which were refractory to other treatments.

Related Keywords: Kayla M. Sturm, PharmD Candidate, Michael Collin, RPh, FIACP, low-dose naltrexone, opioid antagonist, complex regional pain syndrome type I, extremity pain, CRPS, chronic pain syndromes, neuropathic pain, patient distress, case study, adverse effects, drug interactions, formulation

Related Categories: FORMULATIONS, PAIN MANAGEMENT, CASE REPORTS, ADVERSE DRUG EVENTS, NEUROLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients Sturn Kayla M, Collin Michael	May/Jun 2016 Pg. 197-201
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III	May/Jun 2010 Pg. 182-192
Topical Ketamine in the Treatment of Complex Regional Pain Syndrome Durham Melissa J, Mekhjian Hovik S, Goad Jeffery A, Lou Mimi, Ding Michelle, Richeimer Steven H	Mar/Apr 2018 Pg. 172-175
Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report Zur Eyal	Jan/Feb 2014 Pg. 14-19
Clinical Nuggets and Pearls: Chronic Neuropathic Pain and Opioid Tolerance Jones Marty	Jan/Feb 2002 Pg. 4-6
Oral Methadone for Management of Regional Sympathetic Dystrophy Syndrome: A Case Revisited Vail Jane	May/Jun 2007 Pg. 187-192
Topical Medications for Orofacial Neuropathic Pain Bramwell Bethany L	May/Jun 2010 Pg. 200-203
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi	Jul/Aug 2015 Pg. 295-300
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Rabi Joseph	Mar/Apr 2016 Pg. 107-113
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Jul/Aug 2014 Pg. 278-286